BRICS Summit begins tomorrow: China-India bilateral ties may overshadow India's agenda at meet

Agencies
September 3, 2017

Sept 3: The three-day BRICS summit is set to begin on Sunday in China's southwestern city of Xiamen where Prime Minister Narendra Modi and Chinese president Xi Jinping are likely to meet on the sidelines.

Although economic, security and other multilateral issues will figure in the annual meet of the five-member grouping, a probable one-on-one between Modi and Xi will be a focal point, especially after the protracted military standoff along the trijunction point in Doka La.

Their last bilateral meet was during the Shanghai Cooperation Organisation meet at Astana in June. They met informally at G20 in Germany the following month amid the border crisis.

What to expect at BRICS summit

Modi will arrive in China on 3 September and attend the BRICS restricted session and its plenary session on 4 September, External Affairs spokesperson Raveesh Kumar said.

He said the restricted session is expected to discuss the global economic situation, international economic governance, national security and development and international and regional issues.

Kumar said the plenary session will discuss the practical cooperation for common development, people-to-people exchanges, cultural cooperation and institution building. In the evening, the BRICS leaders will attend a cultural festival and an exhibition, followed by a meeting with the BRICS business council.

He said later four documents are expected to be signed at the summit — BRICS action agenda for economic and trade development, BRICS action agenda on innovative development, strategic framework for BRICS custom cooperation and MOU between BRICS business council and New Development Bank.

On the fourth evening, the BRICS leaders will be joined by leaders of the five guest countries for a welcome. The guest countries are Thailand, Mexico, Guinea, Egypt and Tajikistan.

On 5 September, there will be BRICS emerging markets-developing countries dialogue, which the spokesperson said is an opportunity for BRICS member countries to exchange views with the developing world and build broader partnership for development.

Issues like counter-terrorism and the global financial crisis will also come for up discussion.

The proposed BRICS rating agency will be one of the key issues at the 9th meet of the grouping, which will be chaired by Xi.

Kumar said the Prime Minister will leave for Myanmar on 5 September afternoon on the second leg of his visit.

China-India bilateral ties may overshadow India's agenda at the summit

Experts opined that the recent face off may make for a soft spot in India-China relationship, prompting New Delhi to divert much of its attention in improving ties with China.

"Since the (Doklam) dispute has been resolved, the Xiamen meeting (bilateral meet between Modi and Xi) will be a turning point," Wang Dehua, an expert at one of China's top think tanks the Chinese Academy of Social Sciences said.

Wang, who was one of the Chinese experts threatening India with war during the standoff at Doklam, said "there was no reason for India and China to be hostile to each other".

"I always advocate 'Chindia' which is integration of China and India. I think it is a turning point. If we work together, the world will listen to us," Wang said.

The troops of India and China were locked in an over two-month standoff over stopping construction of a Chinese road by the Indian Army in Doklam, at the tri-junction of India, China and Bhutan.

The dispute, which had begun to threaten the success of the BRICS summit, was resolved on Monday.

"It's good news that Modi is coming, but the reasons causing such kind of stand-offs increase strategic mistrust," Hu Shisheng, director of the Institute of South and Southeast Asia and Oceania Studies at the China Institute of Contemporary International Relations said.

Asked about the issues he expects that will figure in the meet, Hu said: They (Modi and Xi) should give a kind of signal that this standoff does not happen again."

When questioned what if Modi raises India's concerns over terrorism emanating from Pakistan, Hu said: "This is the time of recovery. They will meet in the general way to discuss bilateral issues."

"It will take some time to recover from the damage," he said referring to the face-off.

Besides this, the symbolism of the BRICS summit is far too important for China as well to allow hostilities with India take over the narrative. Beijing too an be expected to cut down on rhetoric and allow room for normalisation of ties. A report in the media states that the city of Xiamen, where the stage is set to host the summit, is a manifestation of sorts, for Xi's achievements in domestic politics. "Experts on China, India ties point out that Xi takes a lot of pride in his stint in Xiamen — a city he personally took interest in transforming as vice mayor since as early as in 1985 — which is not very common for his otherwise reticent personality, the report added.

India unlikely to bring up Pakistan issue at BRICS summit

Improving ties after the recent face off is work in progress, however, any improvement in the situation would need constant trust building efforts as the memory from Doka La standoff is still raw.

In such a situation, it is unlikely that India will place undue emphasis on Pakistan at the multi-lateral summit as it remains one of the thorny issues between India and China. Even though, India dismissed the Chinese view that it should not raise concerns over Pakistan's links with cross-border terrorism at the BRICS, it is unlikely that Modi would take it up explicitly at the summit to make matters worse with China.

"India attaches high importance to the role of BRICS that has begun a second decade of its partnership for progress and peace. BRICS has important contributions to make in addressing global challenges and upholding world peace and security," Modi said.

Beijing too has ruled out discussion on India's concerns over terrorism emanating from Pakistan at the summit.

Beijing's Belt and Road project, whose key artery the China-Pakistan Economic Corridor passes through a disputed Kashmir area claimed by India, is another sore point between the two nations.

The five-member bloc of Brazil, Russia, India, China and South Africa was formed in 2006. They comprise 42 percent of the world's population, have 23 percent of global GDP and 17 percent share in world trade. The theme of the ninth BRICS summit is `Stronger Partnership for a Brighter Future'.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 16,2020

China on Tuesday justified the killing of an army officer and two soldiers of India and accused Indian troops of crossing a disputed border between the two countries.

Foreign ministry spokesman Zhao Lijian said Indian troops crossed the border line twice on Monday, "provoking and attacking Chinese personnel, resulting in a serious physical confrontation between border forces on the two sides".

An Indian Army officer and two soldiers have been killed in a "violent face-off" with Chinese troops along the Line of Actual Control (LAC), disrupting the fragile peace talks.

"During the de-escalation process underway in the Galwan Valley, a violent face-off took place last night with casualties on both sides," the Indian Army said in a statement.
 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 29,2020

Washington, May 29: US President Donald Trump while speaking with reporters at the White House on Thursday said that he is more liked in India than the media in his own country --the United States.

"I know. And they like me in India. I think they like me in India certainly more than the media likes me in this country, " Trump told reporters at his Oval office.

"And I like Modi (Prime Minister Narendra Modi). I like your prime minister a lot. He's a great gentleman. A great gentleman," he added further while briefing the reporters.

But when asked over ties between India and China, the US President said, "They have a big conflict going with India and China. Two countries with 1.4 billion people. Two countries with very powerful militaries. And India is not happy, and probably China is not happy."

Reiterating his offer to mediate between India and China on the border issue, Trump said that he spoke to Prime Minister Narendra Modi, who is not in "good mood" about the ongoing situation with Beijing.

However, informed sources from the Ministry of External Affairs told ANI on Friday that there has been no recent contact between Prime Minister Modi and the US President. The last conversation between them took place on April 4, 2020, on the subject of hydroxychloroquine.

Asked about his Wednesday's tweet regarding his offer to mediate between India and China, Trump said, "I would do that. If they (China and India) thought it would help." However, Trump did not clarify when did he speak to Modi.

Trump on Wednesday tweeted that he is "ready, willing and able to mediate" between India and China."We have informed both India and China that the United States is ready, willing and able to mediate or arbitrate their now raging border dispute," the US President said.

In response to Trump's mediation offer, India said on Thursday that it is engaged with the Chinese side to resolve the border issue peacefully.

India's Ministry of External Affairs spokesperson Anurag Srivastava said that the two sides have established mechanisms both at military and diplomatic levels to resolve situations that may arise in border areas peacefully through dialogue and "continue to remain engaged through these channels."

Indian and Chinese field commanders have been holding talks on de-escalating the tensions.

China has also struck a conciliatory tone on the border issue with India, saying the two countries pose no threat to each other and should resolve their differences through communication, while not allowing them to overshadow bilateral relations.

"We should never let differences overshadow our relations. We should resolve differences through communication. China and India should be good neighbours of harmonious coexistence and good partners to move forward hand in hand," said Chinese Ambassador to India, Sun Weidong, on Wednesday.

The tensions escalated between India and China following a number of confrontations between soldiers of both armies.

Troops of India and China were engaged in two face-offs in Eastern Ladakh and North Sikkim along the disputed Line of Actual Control (LAC), where troops from both sides suffered injuries early this month.

Studies over the anti-malarial drug, which is believed to cure the highly contagious coronavirus, have shown side-effects, according to the Centers for Disease Control and Prevention and the World Health Organisation. But Trump continues to defend his decision to take hydroxychloroquine saying he believes that it gives an additional level of safety.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.